Skip to main content
    G

    GRI Bio Inc. (GRI)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.34
    -0.06 (-4.29%)

    Market Cap: $3.06M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    GRI Bio Inc. (GRI) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    GRI Bio (GRI) has a latest price of $1.34 on Nov 17, 2026. Its price fell 97.2% over the past 12 months. The month-end price fell 100.0% over the 5 years through Oct 2026, a compound annual decline of 95.2%.

    Price Chart

    From Feb 2021 to Oct 2026, its highest month-end close was $9,620,465.67 in Feb 2022 and its lowest $1.38 in Jul 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart GRI with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for GRI.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 22.5%, and over 6 months it fell 39.9%. The month-end price fell 100.0% over the 3 years through Oct 2026, a compound annual decline of 96.9%.

    PeriodChange
    1 month-7.6%
    3 months-22.5%
    6 months-39.9%
    12 months-97.2%
    12 months, with dividends-97.2%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-100.0%-96.9%
    5 years-100.0%-95.2%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2022, when the price fell 95.2%, and its weakest was 2025, when it fell 98.2%.

    YearCloseChange
    2026 through Oct 2026$1.53-77.9%
    2025$6.91-98.2%
    2024$394.63-97.6%
    2023$16,690.01-95.6%
    2022$377,528.42-95.2%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 22.2% below its 50-day average of $1.72 and 33.9% below its 200-day average of $2.03.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$1.34
    50-day average$1.72-22.2%
    200-day average$2.03-33.9%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 100.0%.

    MeasureValue
    1-year beta0.63
    Largest fall, 1 year-97.8%
    Largest fall, 3 years-100.0%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About GRI

    What is GRI's 1-year price change?

    GRI Bio's price fell 97.2% over the past 12 months. With dividends included, the 12-month total return was -97.2%.

    What is GRI's 5-year price change?

    GRI Bio's month-end price fell 100.0% over the 5 years through Oct 2026, a compound annual decline of 95.2%. These figures leave out dividends.

    What is GRI's beta?

    GRI Bio's 1-year beta against the S&P 500 is 0.63, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 97.8%.

    Is the GRI chart free?

    Yes. Advanced Charting for GRI is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.